ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
ProfoundBio has raised $112.0M in total funding. The most recent round was Series B. The last funding was announced in February 2024.
ProfoundBio's investors include HSG, RA Capital Management, OrbiMed, Gaorong Capital, K2VC.
ProfoundBio is headquartered in Seattle, United States.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
ProfoundBio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProfoundBio — Funding & Investors." VCBacked, February 13, 2024, https://www.vcbacked.co/company/profoundbio. Accessed July 19, 2026.
VCBacked. (2024). ProfoundBio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/profoundbio
{{cite web |title=ProfoundBio — Funding & Investors |url=https://www.vcbacked.co/company/profoundbio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated